TXN2 and neoplasm: In agreement with our in vitro findings that inhibition of TRX2 with GV potentiates PRX3 adduction (Fig 2) and sensitizes MM cells to TS [34], administrating a combination of TS and GV led to the largest reduction in tumor volume in vivo (Fig 6).